The role of interleukin-17 inhibition in systemic lupus erythematosus-paradoxical hindrance or new therapeutic potential? Results from a systematic literature review and mendelian randomization.

Saved in:
Bibliographic Details
Title: The role of interleukin-17 inhibition in systemic lupus erythematosus-paradoxical hindrance or new therapeutic potential? Results from a systematic literature review and mendelian randomization.
Authors: Nagra D; Department of Rheumatology, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom.; Centre for Rheumatic Disease, King's College London, London, United Kingdom., Zuckerman B; Centre for Rheumatic Disease, King's College London, London, United Kingdom., Odia J; Department of Rheumatology, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom., Patel S; Centre for Rheumatic Disease, King's College London, London, United Kingdom., Ong M; Centre for Rheumatic Disease, King's College London, London, United Kingdom., Adas M; Centre for Rheumatic Disease, King's College London, London, United Kingdom., Yang Z; Centre for Rheumatic Disease, King's College London, London, United Kingdom., Bechman K; Centre for Rheumatic Disease, King's College London, London, United Kingdom., Russell M; Centre for Rheumatic Disease, King's College London, London, United Kingdom., Bhandari S; Department of Rheumatology, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom., Rosa C; Department of Rheumatology, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom., Banerjee S; Department of Rheumatology, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom., Blake T; Department of Rheumatology, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom., Gullick N; Department of Rheumatology, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom., Kasavkar G; Department of Rheumatology, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom., Wincup C; Centre for Rheumatic Disease, King's College London, London, United Kingdom.
Source: Frontiers in immunology [Front Immunol] 2026 Mar 16; Vol. 17, pp. 1706949. Date of Electronic Publication: 2026 Mar 16 (Print Publication: 2026).
Publication Type: Journal Article; Systematic Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first